Femasys inc. announces financial results for the first quarter ended march 31, 2022

- furthers advancement of much-needed minimally invasive technologies for underserved areas of women's health with pending commercialization of products, femcerv ® and femcath ™ expected by year-end
FEMY Ratings Summary
FEMY Quant Ranking